Literature DB >> 25336014

Transient renal dysfunction with reversible splenial lesion.

Toru Watanabe1, Tomoka Matsuda, Ryoichi Kitagata, Iwao Tajima, Hiroyuki Ono, Keiko Hirano, Masami Shirai, Akira Endoh, Teruaki Hongo.   

Abstract

We report the case of a 6-month-old boy with transient renal dysfunction who had an intensified signal in the splenium of the corpus callosum on magnetic resonance imaging. He presented to hospital with fever and sudden disturbance of consciousness. Cerebrospinal fluid analysis did not show pleocytosis. The mild consciousness disturbance disappeared after 30 min, but the splenial signal persisted even after 8 days. Further, renal glucosuria, increased excretion of select amino acids, and abnormal fractional excretion of electrolytes were observed, indicating renal tubular dysfunction. The abnormal urinary findings spontaneously resolved by day 9 of hospitalization. The splenial lesion took 21 days to normalize. There were no signs of neurological complications 2 months later. This case suggests the possibility of renal involvement in splenial lesions.
© 2014 Japan Pediatric Society.

Entities:  

Keywords:  Fanconi syndrome; apparent life-threatening event; central nervous system symptom; corpus callosum; mild encephalitis/encephalopathy with reversible splenial lesion

Mesh:

Year:  2014        PMID: 25336014     DOI: 10.1111/ped.12412

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  A case of reversible splenial lesion syndrome secondary to Fanconi syndrome with white matter swelling as the main manifestation.

Authors:  Jingzhe Han; Yaye Wang; Yue Wu; Jinru Zhang; Xueqin Song; Guang Ji
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

2.  Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature.

Authors:  Chunrong Li; Xiujuan Wu; Hehe Qi; Yanwei Cheng; Bing Zhang; Hongwei Zhou; Xiaohong Lv; Kangding Liu; Hong-Liang Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.